Dynavax Technologies Corporation (DVAX)

Dynavax Technologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	132.03	150.28	202	436.41	32.31	40.1
Short-Term Investments	591.51	592.02	422.39	109.76	132.96	111.17
Cash & Cash Equivalents	723.54	742.3	624.4	546.17	165.27	151.27
Cash Growth	10.94%	18.88%	14.32%	230.46%	9.26%	3.50%
Receivables	46.15	44.53	147.52	131.82	22.66	8.89
Inventory	61.81	53.29	59.45	61.34	63.69	41.33
Other Current Assets	19.79	19	85.63	233.2	38.39	7.16
Total Current Assets	851.29	859.12	916.99	972.52	290.02	208.65
Property, Plant & Equipment	59.81	61.58	63.34	60.98	57.15	62.27
Goodwill and Intangibles	2.02	2.07	2.01	2.13	2.3	4.58
Other Long-Term Assets	73.45	74.33	3.52	3.62	3.81	3.56
Total Long-Term Assets	135.28	137.98	68.87	66.73	63.26	70.42
Total Assets	986.57	997.1	985.85	1,039	353.27	279.07
Accounts Payable	2.43	5.25	3.21	2.6	3.31	9.28
Deferred Revenue	0	0	0	349.86	38.21	0
Other Current Liabilities	53.57	56.95	146.86	203.94	35.89	43.77
Total Current Liabilities	56	62.2	150.07	556.4	77.41	53.05
Long-Term Debt	251.54	252.42	254.38	254.81	214.6	216.45
Other Long-Term Liabilities	60.54	60.41	0.38	5.66	2.57	1.29
Total Long-Term Liabilities	312.08	312.83	254.76	260.47	217.17	217.73
Total Liabilities	368.09	375.02	404.84	816.87	294.58	270.78
Total Debt	251.54	252.42	254.38	254.81	214.6	216.45
Debt Growth	-0.96%	-0.77%	-0.17%	18.74%	-0.85%	114.58%
Retained Earnings	-939.31	-930.58	-924.2	-1,217.35	-1,294.06	-1,218.82
Comprehensive Income	-4.37	-2.11	-5.44	-2.27	0.27	-2.39
Shareholders' Equity	618.48	622.07	581.01	222.37	58.69	8.29
Net Cash / Debt	472	489.88	370.02	291.36	-49.33	-65.18
Net Cash / Debt Growth	18.54%	32.40%	26.99%	-	-	-
Net Cash Per Share	3.63	3.81	2.45	2.19	-0.49	-0.90
Working Capital	795.28	796.93	766.91	416.12	212.6	155.61
Book Value Per Share	4.75	4.83	4.60	1.91	0.58	0.12

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).